Curis Lifesciences IPO Subscription Day 1: Check Online

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Fri Nov 07 2025

Check Expert’s Verdicts on Curis Lifesciences IPO.

Here is the Curis Lifesciences IPO launched on 7th November 2025. Bidding for the issue will close on 11th November 2025. The primary aim of the Curis Lifesciences IPO is to raise ₹27.52 crores from the market. Additionally, the Curis Lifesciences IPO has received an impressive level of subscription, indicating that the shares will likely be listed at a premium. Scroll down to check the Curis Lifesciences IPO subscription and details.

Table of Contents

Curis Lifesciences IPO Details

IPO Open Date	7th November 2025
Face Value	₹10 per share
Price Band	₹120 to ₹128 per share
Lot Size	1,000 shares
Issue Type	Bookbuilding IPO
Listing At	BSE & SME
IPO Close Date	11th November 2025
Listing Date	14th November 2025

The price band for the Curis Lifesciences IPO has been prescribed at ₹120 to ₹128 per share, with a total of 21,50,000 shares issued. Let’s segregate the share quota fixed for different categories of investors.

Categories	Shares Offered	% Shares Offered
Market Maker Shares Offered	1,08,000	5.02%
QIB Shares Offered	10,18,000	47.35%
NII (HNI) Shares Offered	3,08,000	14.33%
Retail Investors	7,16,000	33.20%
Total Shares Offered	21,50,000	100.00%

Curis Lifesciences IPO Subscription Status

As of now, the Curis Lifesciences IPO has been subscribed to 1.27 times. Of these, 0.26 times are subscribed by retail investors, 0.64 times by non-institutional investors, and 3.50 times by QII (Qualified Institutional Investors).

The healthy subscription status indicates that investors are expecting higher returns at the time of the Curis Lifesciences IPO, scheduled for listing on 14th November 2025. Curis Lifesciences’s IPO also has a positive outlook, with the fresh issue of 22.00.000 shares to raise around Rs 27.52 crores.

Curis Lifesciences IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Curis Lifesciences IPO GMP for 7th November 2025.

The grey market premium for this IPO is 5.86% or Rs 7.5 per share. It indicates that the estimated listing price per share is Rs 135.5. Numerous factors played a pivotal role in the jump in Curis Lifesciences IPO GMP. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs.

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Listing Gains
10-11-2025	–	–	–	–
9-11-2025	–	–	–	–
8-11-2025	–	–	–	–
7-11-2025	₹128.00	₹7.50	₹135.5	5.86%
6-11-2025	₹128.00	₹7.50	₹135.5	5.86%
5-11-2025	₹128.00	₹6.00	₹134.00	4.69%
4-11-2025	₹128.00	₹0.00	₹128.00	0.00%
3-11-2025	₹128.00	₹0.00	₹128.00	0.00%
2-11-2025	₹128.00	₹0.00	₹128.00	0.00%
1-11-2025	₹128.00	₹0.00	₹128.00	0.00%

About Curis Lifesciences IPO Ltd.

Curis Lifesciences Limited was established in 2010 and is a prominent pharmaceutical company that engages in the development, manufacturing, and distribution of various products. It has manufacturing units globally and domestically, through licenses and on a contract basis, and it markets its own brand.

Experienced Promoters and Management Team
Wide range of Products
Strategic Location of Manufacturing Facility
Scalable Business Model
Quality assurance

Curis Lifesciences Limited Financials

The company’s financial analysis is essential before applying for Curis Lifesciences Limited’s IPO. Look at the table to learn about Curis Lifesciences Limited’s financials.

Year Ended	31st July 2025	31st March 2025 (in cr.)	31st March 2024 (in cr.)	31st March 2023 (in cr.)
Assets	56.29	42.53	33.88	29.75
Revenue	19.51	49.65	35.87	36.42
Profit After Tax	2.87	6.11	487	1.88
EBITDA	4.24	9.54	8.39	3.28
Net Worth	19.10	16.23	5.87	1.01
Reserve and Surplus	13.16	10.29	5.37	0.51
Total Borrowing	15.32	15.62	17.09	16.19

Explanation

Curis Lifesciences Limited’s revenue increased by 38% from ₹4.87 crore in March 2024 to ₹ 6.49 crore in March 2025. Moreover, the company’s PAT increased by 25% from ₹4.87 crores to ₹6.11 crores. Investors can analyse other relevant factors and make a decision accordingly.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Curis Lifesciences IPO.

Key Indicators	Value
PE Ratio (Price-to-Earnings)	12.44
EPS (Earnings Per Share)	10.29
RoNW	37.62%
ROCE	27.83%
ROE	55.25%
EBITDA Margin	19.41%
Price to Book Value	12.64
Market Capitalisation	₹103.48

Curis Lifesciences IPO Listing Expectations

Curis Lifesciences IPO Highlights: IPO allotment is still pending, as the bid closes today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A 5.86% jump in the GMP of Curis Lifesciences’ IPO suggests that the estimated listing price per share will be around Rs 135.5.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation.

Curis Lifesciences IPO Dates

IPO Open Date	7th November 2025
IPO Close Date	11th November 2025
Allotment	12th November 2025
Refund Date	13th November 2025
IPO Listing Date	14th November 2025

Note: IPO GMP is volatile, driven by market sentiment. Hence, one should conduct their research before investing in it.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!